RENASCIENCE PHARMA LIMITED
Company number 09420886 · Active · Slough SL1 2BE
RENASCIENCE PHARMA LIMITED is an active private limited company (company number 09420886) incorporated on 4 February 2015, registered in Slough. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest full accounts cover the period ending 31 March 2025, showing net assets of £960k and cash of £902k, with 4 employees on average. Turnover was £3.68m and profit for the year £1.31m. Net assets rose 286% on the prior period (£249k).
By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
Key dates
- Incorporated
- 4 February 2015
- Next accounts due
- 31 December 2026 — in 70 days
- Confirmation statement due
- 18 February 2027 — in 119 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Full
- Size band
- Small (Companies Act thresholds)
Financials — 3 periods on record, latest ending 31 March 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £960k | £902k | £720k | — | £3.68m | £1.31m | 4 |
| 29 February 2024 | £249k | £348k | £107k | — | £1.87m | £541k | 4 |
| 1 March 2023 | — | — | — | — | — | — | — |
- Net margin
- 35.6%
- Cash per employee
- £226k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 85/100 (grade A)
- +10 Positive net assets — Net assets £959,782 at 2025-03-31
- +8 Net assets growing — +285.8% vs prior period
- +4 Cash reserves — Cash £902,272
- +5 Multi-year filing history — 3 periods on record
- +8 Established — Incorporated 2015-02-04 (12 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Lupin Healthcare (Uk) Limited (corporate entity, United Kingdom) — owns 75–100% of shares; holds 75–100% of voting rights · since 2 April 2025
- Mr Ka Yan Che — has significant influence or control · since 4 February 2017 · ceased 2 April 2025
- Mr Mobeen Akhtar — has significant influence or control · since 4 February 2017 · ceased 2 April 2025
- Mr Peter Mollison — has significant influence or control · since 4 February 2017 · ceased 2 April 2025
- Mr Haziq Patel — has significant influence or control · since 4 February 2017 · ceased 2 April 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Reading
Same activity (manufacture of basic pharmaceutical products), closest in incorporation date.
- SKINNYTAN UK LIMITED — Iver, inc. Dec 2014
- CRESCENT MEDICAL UK LIMITED — Basingstoke, inc. Sept 2014
- RENEW MEDICAL UK LIMITED — Reading, inc. Sept 2014
- INCEPTA PHARMA UK LIMITED — Marlow, inc. Jul 2015
- CRESCENT MANUFACTURING LIMITED — Basingstoke, inc. Dec 2015
- NORRDIA UK CO., LTD — Reading, inc. Nov 2013
All companies incorporated on 4 February 2015 · in Feb 2015.
Reminders for RENASCIENCE PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.